company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q1,2010-01-01,2010-03-31,2011-05-03 16:24:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,17288000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q1,2010-01-01,2010-03-31,2011-05-03 16:24:07+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,17288000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q1,2010-01-01,2010-03-31,2011-05-03 16:24:07+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,17288000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q1,2010-01-01,2010-03-31,2011-05-03 16:24:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5679000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q1,2010-01-01,2010-03-31,2011-05-03 16:24:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,31439000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q1,2010-01-01,2010-03-31,2011-05-03 16:24:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,37118000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q1,2010-01-01,2010-03-31,2011-05-03 16:24:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-19830000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q1,2010-01-01,2010-03-31,2011-05-03 16:24:07+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,15767000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q1,2010-01-01,2010-03-31,2011-05-03 16:24:07+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,195000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q1,2010-01-01,2010-03-31,2011-05-03 16:24:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-15572000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q1,2010-01-01,2010-03-31,2011-05-03 16:24:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-35402000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q1,2010-01-01,2010-03-31,2011-05-03 16:24:07+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,327000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q1,2010-01-01,2010-03-31,2011-05-03 16:24:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-35729000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q1,2010-01-01,2010-03-31,2011-05-03 16:24:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-35729000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q1,2010-01-01,2010-03-31,2011-05-03 16:24:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-35729000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q1,2010-01-01,2010-03-31,2011-05-03 16:24:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,119727000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q1,2010-01-01,2010-03-31,2011-05-03 16:24:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.3
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q1,2010-01-01,2010-03-31,2011-05-03 16:24:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,119727000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q1,2010-01-01,2010-03-31,2011-05-03 16:24:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.3
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q1,2010-01-01,2010-03-31,2011-05-03 16:24:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,119100000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q1,2010-01-01,2010-03-31,2011-05-03 16:24:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.3
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 16:13:32+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,49847000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 16:13:32+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,49847000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 16:13:32+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,49847000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 16:13:32+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7340000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 16:13:32+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,28883000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 16:13:32+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,36223000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 16:13:32+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,13624000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 16:13:32+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,10391000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 16:13:32+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,142000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 16:13:32+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-10249000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 16:13:32+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3375000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 16:13:32+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,331000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 16:13:32+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3044000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 16:13:32+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3044000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 16:13:32+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3044000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 16:13:32+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,121630000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 16:13:32+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.03
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 16:13:32+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,128291000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 16:13:32+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.02
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 16:13:32+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,101500000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 16:13:32+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.03
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 16:25:59+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,16872000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 16:25:59+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,16872000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 16:25:59+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,16872000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 16:25:59+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8319000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 16:25:59+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,30609000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 16:25:59+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,38928000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 16:25:59+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-22056000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 16:25:59+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,10515000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 16:25:59+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,212000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 16:25:59+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-10303000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 16:25:59+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-32359000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 16:25:59+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-658000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 16:25:59+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-31701000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 16:25:59+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-31701000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 16:25:59+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-31701000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 16:25:59+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,122189000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 16:25:59+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 16:25:59+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,122189000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 16:25:59+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 16:25:59+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,121900000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 16:25:59+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.26
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q4,2010-10-01,2010-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,84941000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q4,2010-10-01,2010-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,930000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q4,2010-10-01,2010-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,85871000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,85871000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10611000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,32949000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,43560000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q4,2010-10-01,2010-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,42311000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q4,2010-10-01,2010-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,6650000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q4,2010-10-01,2010-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,867000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q4,2010-10-01,2010-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3988000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q4,2010-10-01,2010-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-9771000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,32540000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q4,2010-10-01,2010-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,32540000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q4,2010-10-01,2010-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,32540000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q4,2010-10-01,2010-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,32540000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q4,2010-10-01,2010-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,122500000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q4,2010-10-01,2010-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.01
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q4,2010-10-01,2010-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,122500000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q4,2010-10-01,2010-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.02
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q4,2010-10-01,2010-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,121628000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2010.0,Q4,2010-10-01,2010-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.27
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q1,2011-01-01,2011-03-31,2011-05-03 16:24:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,31973000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q1,2011-01-01,2011-03-31,2011-05-03 16:24:07+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,31973000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q1,2011-01-01,2011-03-31,2011-05-03 16:24:07+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,31973000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q1,2011-01-01,2011-03-31,2011-05-03 16:24:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11516000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q1,2011-01-01,2011-03-31,2011-05-03 16:24:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,36282000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q1,2011-01-01,2011-03-31,2011-05-03 16:24:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,47798000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q1,2011-01-01,2011-03-31,2011-05-03 16:24:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15825000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q1,2011-01-01,2011-03-31,2011-05-03 16:24:07+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,10759000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q1,2011-01-01,2011-03-31,2011-05-03 16:24:07+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,72000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q1,2011-01-01,2011-03-31,2011-05-03 16:24:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-10687000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q1,2011-01-01,2011-03-31,2011-05-03 16:24:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-26512000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q1,2011-01-01,2011-03-31,2011-05-03 16:24:07+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q1,2011-01-01,2011-03-31,2011-05-03 16:24:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-26512000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q1,2011-01-01,2011-03-31,2011-05-03 16:24:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-26512000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q1,2011-01-01,2011-03-31,2011-05-03 16:24:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-26512000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q1,2011-01-01,2011-03-31,2011-05-03 16:24:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,123467000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q1,2011-01-01,2011-03-31,2011-05-03 16:24:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.21
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q1,2011-01-01,2011-03-31,2011-05-03 16:24:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,123467000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q1,2011-01-01,2011-03-31,2011-05-03 16:24:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.21
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q1,2011-01-01,2011-03-31,2011-05-03 16:24:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,126200000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q1,2011-01-01,2011-03-31,2011-05-03 16:24:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.21
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q2,2011-04-01,2011-06-30,2012-08-03 16:12:20+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,16811000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q2,2011-04-01,2011-06-30,2012-08-03 16:12:20+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,16811000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q2,2011-04-01,2011-06-30,2012-08-03 16:12:20+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q2,2011-04-01,2011-06-30,2012-08-03 16:12:20+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,16811000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q2,2011-04-01,2011-06-30,2012-08-03 16:12:20+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11878000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q2,2011-04-01,2011-06-30,2012-08-03 16:12:20+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,46047000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q2,2011-04-01,2011-06-30,2012-08-03 16:12:20+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,57925000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q2,2011-04-01,2011-06-30,2012-08-03 16:12:20+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-41114000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q2,2011-04-01,2011-06-30,2012-08-03 16:12:20+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,10888000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q2,2011-04-01,2011-06-30,2012-08-03 16:12:20+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,132000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q2,2011-04-01,2011-06-30,2012-08-03 16:12:20+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q2,2011-04-01,2011-06-30,2012-08-03 16:12:20+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-10756000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q2,2011-04-01,2011-06-30,2012-08-03 16:12:20+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-51870000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q2,2011-04-01,2011-06-30,2012-08-03 16:12:20+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q2,2011-04-01,2011-06-30,2012-08-03 16:12:20+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-51870000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q2,2011-04-01,2011-06-30,2012-08-03 16:12:20+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-51870000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q2,2011-04-01,2011-06-30,2012-08-03 16:12:20+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-51870000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q2,2011-04-01,2011-06-30,2012-08-03 16:12:20+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,125330000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q2,2011-04-01,2011-06-30,2012-08-03 16:12:20+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.41
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q2,2011-04-01,2011-06-30,2012-08-03 16:12:20+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,125330000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q2,2011-04-01,2011-06-30,2012-08-03 16:12:20+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.41
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q2,2011-04-01,2011-06-30,2012-08-03 16:12:20+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 16:20:43+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,16737000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 16:20:43+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,45000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 16:20:43+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,16782000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 16:20:43+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 16:20:43+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,16782000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 16:20:43+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,14282000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 16:20:43+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,44604000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 16:20:43+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,58886000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 16:20:43+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-42104000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 16:20:43+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11019000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 16:20:43+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,45000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 16:20:43+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 16:20:43+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-10974000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 16:20:43+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-53078000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 16:20:43+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 16:20:43+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-53078000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 16:20:43+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-53078000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 16:20:43+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-53078000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 16:20:43+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,0.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 16:20:43+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 16:20:43+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,0.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 16:20:43+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 16:20:43+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,126260000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 16:20:43+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.42
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,28439000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,450000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,28889000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,28889000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,21255000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,51774000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,73029000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-44140000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11153000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,213000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-10940000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-55080000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-55080000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-55080000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q4,2011-10-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-55080000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q4,2011-10-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,125200000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q4,2011-10-01,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.87
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q4,2011-10-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,125200000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q4,2011-10-01,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.87
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q4,2011-10-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,125362000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2011.0,Q4,2011-10-01,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.86
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 16:30:47+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,36016000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 16:30:47+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,163000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 16:30:47+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,36179000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 16:30:47+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,11000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 16:30:47+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,11000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 16:30:47+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,36168000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 16:30:47+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,21396000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 16:30:47+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,48960000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 16:30:47+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,70356000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 16:30:47+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-34188000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 16:30:47+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11290000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 16:30:47+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,52000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 16:30:47+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-11238000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 16:30:47+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-45426000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 16:30:47+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-45426000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 16:30:47+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-45426000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 16:30:47+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-45426000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 16:30:47+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,126200000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 16:30:47+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.36
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 16:30:47+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,126200000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 16:30:47+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.36
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 16:30:47+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,127203000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 16:30:47+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.36
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:07:00+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,86464000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:07:00+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,78000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:07:00+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,86542000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:07:00+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,16000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:07:00+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,16000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:07:00+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,86526000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:07:00+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,19719000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:07:00+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,51588000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:07:00+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,71307000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:07:00+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,15219000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:07:00+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11430000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:07:00+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,315000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:07:00+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-11115000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:07:00+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4104000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:07:00+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,67000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:07:00+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4037000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:07:00+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4037000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:07:00+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4037000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:07:00+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,129224000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:07:00+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.03
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:07:00+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,137969000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:07:00+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.03
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:07:00+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,134600000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:07:00+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.03
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q3,2012-07-01,2012-09-30,2013-10-31 16:12:49+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,60432000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q3,2012-07-01,2012-09-30,2013-10-31 16:12:49+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,60000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q3,2012-07-01,2012-09-30,2013-10-31 16:12:49+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,60492000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q3,2012-07-01,2012-09-30,2013-10-31 16:12:49+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,31000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q3,2012-07-01,2012-09-30,2013-10-31 16:12:49+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,31000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q3,2012-07-01,2012-09-30,2013-10-31 16:12:49+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,60461000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q3,2012-07-01,2012-09-30,2013-10-31 16:12:49+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,20520000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q3,2012-07-01,2012-09-30,2013-10-31 16:12:49+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,50079000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q3,2012-07-01,2012-09-30,2013-10-31 16:12:49+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,70599000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q3,2012-07-01,2012-09-30,2013-10-31 16:12:49+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10138000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q3,2012-07-01,2012-09-30,2013-10-31 16:12:49+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11573000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q3,2012-07-01,2012-09-30,2013-10-31 16:12:49+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,27000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q3,2012-07-01,2012-09-30,2013-10-31 16:12:49+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-11546000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q3,2012-07-01,2012-09-30,2013-10-31 16:12:49+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-21684000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q3,2012-07-01,2012-09-30,2013-10-31 16:12:49+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,26000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q3,2012-07-01,2012-09-30,2013-10-31 16:12:49+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21710000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q3,2012-07-01,2012-09-30,2013-10-31 16:12:49+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21710000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q3,2012-07-01,2012-09-30,2013-10-31 16:12:49+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-21710000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q3,2012-07-01,2012-09-30,2013-10-31 16:12:49+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,127700000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q3,2012-07-01,2012-09-30,2013-10-31 16:12:49+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.17
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q3,2012-07-01,2012-09-30,2013-10-31 16:12:49+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,127700000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q3,2012-07-01,2012-09-30,2013-10-31 16:12:49+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.17
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q3,2012-07-01,2012-09-30,2013-10-31 16:12:49+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,130851000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q3,2012-07-01,2012-09-30,2013-10-31 16:12:49+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.17
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,113689000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,157000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,113846000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q4,2012-10-01,2012-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,99000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,99000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,113747000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,23728000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,59764000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,83492000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,30255000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11765000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,370000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-11395000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,18860000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,81000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,18779000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,18779000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,18779000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,130400000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.16
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,130400000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.16
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,129747000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.16
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 16:08:57+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,70935000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 16:08:57+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,142000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 16:08:57+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,71077000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 16:08:57+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,150000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 16:08:57+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,150000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 16:08:57+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,70927000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 16:08:57+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,22261000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 16:08:57+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,52763000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 16:08:57+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,75024000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 16:08:57+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4097000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 16:08:57+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11728000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 16:08:57+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,199000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 16:08:57+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-11529000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 16:08:57+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-15626000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 16:08:57+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,43000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 16:08:57+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15669000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 16:08:57+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15669000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 16:08:57+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-15669000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 16:08:57+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,130600000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 16:08:57+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.12
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 16:08:57+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,130600000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 16:08:57+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.12
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 16:08:57+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,134345000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 16:08:57+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.12
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 16:07:52+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,101636000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 16:07:52+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,39000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 16:07:52+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,101675000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 16:07:52+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,157000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 16:07:52+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,157000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 16:07:52+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,101518000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 16:07:52+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,23249000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 16:07:52+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,60950000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 16:07:52+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,84199000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 16:07:52+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,17319000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 16:07:52+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,20064000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 16:07:52+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,245000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 16:07:52+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-19819000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 16:07:52+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2500000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 16:07:52+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,71000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 16:07:52+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2571000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 16:07:52+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2571000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 16:07:52+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2571000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 16:07:52+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,128600000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 16:07:52+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.02
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 16:07:52+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,128600000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 16:07:52+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.02
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 16:07:52+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,142284000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 16:07:52+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.02
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 16:37:16+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,85122000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 16:37:16+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,1000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 16:37:16+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,85123000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 16:37:16+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,155000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 16:37:16+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,155000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 16:37:16+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,84968000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 16:37:16+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,26447000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 16:37:16+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,71704000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 16:37:16+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,98151000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 16:37:16+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-13183000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 16:37:16+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9190000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 16:37:16+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,385000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 16:37:16+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-8805000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 16:37:16+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-21988000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 16:37:16+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,49000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 16:37:16+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22037000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 16:37:16+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22037000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 16:37:16+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-22037000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 16:37:16+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,155067000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 16:37:16+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.14
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 16:37:16+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,155067000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 16:37:16+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.14
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 16:37:16+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,157400000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 16:37:16+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.14
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,97048000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,24000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,97072000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q4,2013-10-01,2013-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,168000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,168000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,96904000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,38026000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,75019000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,113045000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-16141000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9154000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,495000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-17934000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-26593000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-42734000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,136000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-42870000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-42870000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-42870000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,148403000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.28
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,148403000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.28
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,148500000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.28
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:45:12+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,89691000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:45:12+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,101000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:45:12+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,89792000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:45:12+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,168000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:45:12+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,168000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:45:12+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,89624000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:45:12+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,36974000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:45:12+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,75585000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:45:12+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,112559000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:45:12+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-22935000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:45:12+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11708000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:45:12+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,735000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:45:12+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-10973000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:45:12+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-33908000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:45:12+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,49000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:45:12+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-33957000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:45:12+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-33957000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:45:12+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-33957000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:45:12+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,161700000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:45:12+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.21
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:45:12+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,161700000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:45:12+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.21
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:45:12+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,165357000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:45:12+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.21
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:09:56+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,99579000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:09:56+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,3000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:09:56+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,99582000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:09:56+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,187000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:09:56+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,187000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:09:56+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,99395000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:09:56+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,40899000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:09:56+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,84683000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:09:56+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,125582000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:09:56+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-26187000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:09:56+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11406000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:09:56+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,790000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:09:56+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-10616000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:09:56+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-36803000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:09:56+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,70000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:09:56+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-36873000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:09:56+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-36873000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:09:56+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-36873000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:09:56+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,167914000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:09:56+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.22
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:09:56+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,167914000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:09:56+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.22
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:09:56+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,167600000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:09:56+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.22
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 16:16:16+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,198144000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 16:16:16+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,3000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 16:16:16+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,198147000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 16:16:16+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,221000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 16:16:16+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,221000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 16:16:16+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,197926000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 16:16:16+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,39446000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 16:16:16+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,88537000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 16:16:16+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,127983000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 16:16:16+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,69943000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 16:16:16+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11463000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 16:16:16+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,885000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 16:16:16+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-10578000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 16:16:16+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,59365000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 16:16:16+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,72000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 16:16:16+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,59293000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 16:16:16+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,59293000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 16:16:16+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,59293000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 16:16:16+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,168592000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 16:16:16+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.35
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 16:16:16+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,189046000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 16:16:16+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.33
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 16:16:16+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,169400000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 16:16:16+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.35
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,123971000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,3000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,123974000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q4,2014-10-01,2014-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2428000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2428000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,121546000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,48453000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,98718000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,147171000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-25625000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,12516000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,940000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-11576000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-37201000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-257000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-36944000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-36944000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-36944000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,167947000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.21
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,167947000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.19
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,167200000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.21
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:50:57+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,159217000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:50:57+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,58000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:50:57+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,159275000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:50:57+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2974000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:50:57+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2974000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:50:57+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,156301000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:50:57+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,44871000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:50:57+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,118365000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:50:57+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,163236000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:50:57+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6935000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:50:57+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,12687000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:50:57+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1630000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:50:57+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-11057000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:50:57+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-17992000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:50:57+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,367000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:50:57+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18359000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:50:57+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18359000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:50:57+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-18359000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:50:57+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,172070000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:50:57+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.11
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:50:57+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,172070000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:50:57+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.11
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:50:57+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,166900000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:50:57+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.11
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:57:43+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,162984000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:57:43+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,162984000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:57:43+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6254000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:57:43+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6254000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:57:43+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,156730000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:57:43+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,51679000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:57:43+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,112445000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:57:43+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,164124000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:57:43+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7394000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:57:43+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11494000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:57:43+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1144000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:57:43+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,27174000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:57:43+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,16824000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:57:43+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,9430000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:57:43+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,136000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:57:43+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,9294000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:57:43+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,9294000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:57:43+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,9294000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:57:43+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,178676000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:57:43+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.05
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:57:43+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,186493000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:57:43+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.05
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:57:43+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,185900000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:57:43+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.05
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 16:11:45+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,187611000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 16:11:45+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,187611000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 16:11:45+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,8040000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 16:11:45+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,8040000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 16:11:45+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,179571000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 16:11:45+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,47599000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 16:11:45+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,132073000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 16:11:45+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,179672000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 16:11:45+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-101000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 16:11:45+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11209000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 16:11:45+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3026000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 16:11:45+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-31289000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 16:11:45+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-39472000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 16:11:45+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-39573000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 16:11:45+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,9000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 16:11:45+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-39582000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 16:11:45+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-39582000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 16:11:45+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-39582000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 16:11:45+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,181387000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 16:11:45+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.22
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 16:11:45+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,181387000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 16:11:45+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.22
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 16:11:45+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,179900000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 16:11:45+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.22
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,243881000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,243881000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q4,2015-10-01,2015-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,9704000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,9704000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,234177000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,52465000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,116631000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,169096000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,65081000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,10213000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1289000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-466000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-9390000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,55691000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,513000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,55178000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,55178000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,55178000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,179601000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.32
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,187302000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.31
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,163300000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.32
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:23:14+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,263384000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:23:14+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,80000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:23:14+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,263464000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:23:14+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6005000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:23:14+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6005000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:23:14+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,257459000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:23:14+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,64596000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:23:14+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,156824000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:23:14+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,221420000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:23:14+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,36039000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:23:14+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,10134000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:23:14+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1492000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:23:14+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2950000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:23:14+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-11592000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:23:14+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,24447000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:23:14+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,400000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:23:14+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,24047000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:23:14+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,24047000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:23:14+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,24047000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:23:14+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,187184000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:23:14+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.13
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:23:14+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,192625000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:23:14+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.12
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:23:14+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,185000000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:23:14+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.13
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 16:02:49+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,246288000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 16:02:49+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,246288000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 16:02:49+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,12367000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 16:02:49+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,12367000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 16:02:49+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,233921000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 16:02:49+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,66792000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 16:02:49+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,120269000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 16:02:49+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,2271000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 16:02:49+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,189332000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 16:02:49+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,44589000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 16:02:49+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9662000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 16:02:49+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1137000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 16:02:49+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-854000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 16:02:49+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-9379000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 16:02:49+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,35210000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 16:02:49+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,785000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 16:02:49+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,34425000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 16:02:49+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,34425000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 16:02:49+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,34425000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 16:02:49+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,187682000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 16:02:49+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.18
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 16:02:49+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,193015000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 16:02:49+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.18
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 16:02:49+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,191300000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 16:02:49+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.18
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:03:50+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,269463000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:03:50+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,6000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:03:50+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,269469000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:03:50+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,20205000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:03:50+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,20205000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:03:50+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,249264000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:03:50+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,75776000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:03:50+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,143184000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:03:50+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,8012000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:03:50+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,226972000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:03:50+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,22292000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:03:50+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9479000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:03:50+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1188000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:03:50+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,24301000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:03:50+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,16010000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:03:50+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,38302000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:03:50+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1425000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:03:50+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,36877000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:03:50+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,36877000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:03:50+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,36877000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:03:50+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,188029000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:03:50+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.2
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:03:50+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,194265000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:03:50+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.19
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:03:50+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,184400000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:03:50+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.2
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,326584000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-86000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,326498000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q4,2016-10-01,2016-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,19610000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,19610000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,306888000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,96087000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,161584000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,7139000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,264810000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,42078000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9470000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-2666000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-20497000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-32633000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,9445000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,572000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8873000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,8873000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,8873000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,187873000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.04
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,194125000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.05
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,189500000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.04
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 16:03:35+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,384082000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 16:03:35+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,384082000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 16:03:35+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,14824000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 16:03:35+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,14824000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 16:03:35+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,369258000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 16:03:35+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,87229000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 16:03:35+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,407920000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 16:03:35+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,7356000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 16:03:35+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,502505000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 16:03:35+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-133247000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 16:03:35+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,60069000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 16:03:35+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-5814000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 16:03:35+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1147000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 16:03:35+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-64736000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 16:03:35+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-197983000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 16:03:35+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-10900000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 16:03:35+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-187083000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 16:03:35+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-187083000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 16:03:35+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-187083000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 16:03:35+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,194900000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 16:03:35+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.96
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 16:03:35+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,194900000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 16:03:35+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.96
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 16:03:35+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,195260000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 16:03:35+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.96
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:02:57+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,326444000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:02:57+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,326444000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:02:57+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,20260000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:02:57+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,20260000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:02:57+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,306184000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:02:57+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,90066000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:02:57+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,201786000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:02:57+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,7073000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:02:57+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,298925000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:02:57+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,7259000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:02:57+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1135000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:02:57+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-19574000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:02:57+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,4066000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:02:57+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-16643000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:02:57+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9384000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:02:57+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3100000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:02:57+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12484000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:02:57+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12484000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:02:57+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12484000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:02:57+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,205141000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:02:57+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.06
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:02:57+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,205141000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:02:57+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.06
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:02:57+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,208100000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:02:57+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.06
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 16:02:55+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,381534000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 16:02:55+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,381534000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 16:02:55+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,22036000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 16:02:55+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,22036000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 16:02:55+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,359498000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 16:02:55+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,91265000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 16:02:55+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,269557000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 16:02:55+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-16343000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 16:02:55+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,344479000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 16:02:55+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,15019000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 16:02:55+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,204000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 16:02:55+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,23045000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 16:02:55+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,5494000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 16:02:55+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,28335000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 16:02:55+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,43354000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 16:02:55+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,7300000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 16:02:55+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,36054000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 16:02:55+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,36054000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 16:02:55+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,36054000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 16:02:55+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,206796000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 16:02:55+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.17
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 16:02:55+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,212610000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 16:02:55+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.17
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 16:02:55+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,212100000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 16:02:55+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.17
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,444156000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,444156000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q4,2017-10-01,2017-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,22359000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,22359000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,421797000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,97726000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,446871000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,9618000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,554215000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-132418000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,373000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-21932000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,6446000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-15859000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-148277000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1352000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-149629000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-149629000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-149629000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,204580000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.68
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,204580000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.68
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,204700000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.68
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q1,2018-01-01,2018-03-31,2019-04-30 16:05:32+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,382282000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q1,2018-01-01,2018-03-31,2019-04-30 16:05:32+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,382282000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q1,2018-01-01,2018-03-31,2019-04-30 16:05:32+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,18106000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q1,2018-01-01,2018-03-31,2019-04-30 16:05:32+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,18106000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q1,2018-01-01,2018-03-31,2019-04-30 16:05:32+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,364176000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q1,2018-01-01,2018-03-31,2019-04-30 16:05:32+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,121498000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q1,2018-01-01,2018-03-31,2019-04-30 16:05:32+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,303103000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q1,2018-01-01,2018-03-31,2019-04-30 16:05:32+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,6685000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q1,2018-01-01,2018-03-31,2019-04-30 16:05:32+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,431286000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q1,2018-01-01,2018-03-31,2019-04-30 16:05:32+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-67110000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q1,2018-01-01,2018-03-31,2019-04-30 16:05:32+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,385000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q1,2018-01-01,2018-03-31,2019-04-30 16:05:32+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,22679000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q1,2018-01-01,2018-03-31,2019-04-30 16:05:32+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,4462000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q1,2018-01-01,2018-03-31,2019-04-30 16:05:32+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,26756000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q1,2018-01-01,2018-03-31,2019-04-30 16:05:32+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-40354000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q1,2018-01-01,2018-03-31,2019-04-30 16:05:32+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,786000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q1,2018-01-01,2018-03-31,2019-04-30 16:05:32+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-41140000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q1,2018-01-01,2018-03-31,2019-04-30 16:05:32+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-41140000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q1,2018-01-01,2018-03-31,2019-04-30 16:05:32+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-41140000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q1,2018-01-01,2018-03-31,2019-04-30 16:05:32+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,211681000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q1,2018-01-01,2018-03-31,2019-04-30 16:05:32+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.19
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q1,2018-01-01,2018-03-31,2019-04-30 16:05:32+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,211681000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q1,2018-01-01,2018-03-31,2019-04-30 16:05:32+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.19
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q1,2018-01-01,2018-03-31,2019-04-30 16:05:32+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,216500000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q1,2018-01-01,2018-03-31,2019-04-30 16:05:32+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.19
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 16:06:50+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,521516000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 16:06:50+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,521516000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 16:06:50+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,24856000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 16:06:50+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,24856000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 16:06:50+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,496660000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 16:06:50+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,108029000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 16:06:50+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,298089000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 16:06:50+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,7303000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 16:06:50+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,413421000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 16:06:50+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,83239000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 16:06:50+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,398000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 16:06:50+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-34641000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 16:06:50+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,5808000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 16:06:50+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-29231000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 16:06:50+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,54008000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 16:06:50+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1600000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 16:06:50+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,52408000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 16:06:50+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,52394000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 16:06:50+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,52394000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 16:06:50+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,212210000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 16:06:50+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.25
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 16:06:50+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,215103000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 16:06:50+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.24
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 16:06:50+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,209600000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 16:06:50+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.25
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 19:38:47+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,449683000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 19:38:47+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,449683000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 19:38:47+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,24795000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 19:38:47+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,24795000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 19:38:47+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,424888000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 19:38:47+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,96522000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 19:38:47+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,292527000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 19:38:47+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,4720000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 19:38:47+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,393769000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 19:38:47+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,31119000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 19:38:47+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,405000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 19:38:47+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-9949000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 19:38:47+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,10211000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 19:38:47+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-143000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 19:38:47+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,30976000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 19:38:47+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1800000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 19:38:47+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,29176000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 19:38:47+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,29176000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 19:38:47+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,29176000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 19:38:47+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,212627000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 19:38:47+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.14
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 19:38:47+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,215964000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 19:38:47+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.14
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 19:38:47+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,208400000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 19:38:47+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.14
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,528402000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,528402000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q4,2018-10-01,2018-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,26366000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,26366000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,502036000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,108358000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,304238000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,7465000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,420061000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,81975000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,355000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-22182000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,11279000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-11258000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,70717000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1668000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,69049000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,69063000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,69063000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,212383000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.32
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,215635000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.32
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,210600000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.32
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:09:15+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,497857000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:09:15+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,497857000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:09:15+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,22588000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:09:15+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,22588000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:09:15+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,475269000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:09:15+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,123983000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:09:15+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,270545000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:09:15+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,6671000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:09:15+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,401199000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:09:15+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,74070000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:09:15+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,335000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:09:15+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,20989000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:09:15+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,9373000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:09:15+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,30027000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:09:15+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,104097000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:09:15+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1785000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:09:15+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,102312000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:09:15+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,102312000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:09:15+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,102312000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:09:15+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,214065000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:09:15+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.48
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:09:15+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,217061000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:09:15+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.47
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:09:15+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,213200000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:09:15+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.48
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 16:06:50+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,529932000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 16:06:50+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,529932000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 16:06:50+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,29406000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 16:06:50+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,29406000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 16:06:50+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,500526000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 16:06:50+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,105943000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 16:06:50+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,289363000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 16:06:50+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,6608000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 16:06:50+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,401914000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 16:06:50+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,98612000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 16:06:50+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,316000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 16:06:50+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-4625000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 16:06:50+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,15000000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 16:06:50+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,10059000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 16:06:50+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,108671000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 16:06:50+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3400000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 16:06:50+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,105271000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 16:06:50+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,105318000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 16:06:50+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,105318000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 16:06:50+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,214620000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 16:06:50+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.49
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 16:06:50+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,217483000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 16:06:50+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.48
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 16:06:50+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,214900000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 16:06:50+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.49
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 19:38:47+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,551581000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 19:38:47+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,551581000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 19:38:47+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,30040000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 19:38:47+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,30040000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 19:38:47+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,521541000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 19:38:47+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,102608000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 19:38:47+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,281336000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 19:38:47+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,3281000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 19:38:47+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,387225000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 19:38:47+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,134316000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 19:38:47+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,597000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 19:38:47+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2339000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 19:38:47+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,11961000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 19:38:47+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,13703000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 19:38:47+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,148019000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 19:38:47+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,19700000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 19:38:47+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,128319000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 19:38:47+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,128271000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 19:38:47+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,128271000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 19:38:47+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,215199000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 19:38:47+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.6
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 19:38:47+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,217791000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 19:38:47+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.59
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 19:38:47+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,213800000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 19:38:47+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.6
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q4,2019-10-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,579389000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,579389000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q4,2019-10-01,2019-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,32215000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,32215000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,547174000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,136177000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,312867000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,3122000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,452166000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,95008000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,607000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,15755000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,15848000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,30996000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,126004000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,15000000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,111004000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,111005000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,111005000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,214913000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.51
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,217657000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.51
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,214900000.0
Incyte Corp,INCY,549300Z4WN6JVZ3T4680,0000879169,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.51
